Psoriasis and uveitis
DOI:
https://doi.org/10.47196/da.v29i2.2346Keywords:
psoriasis, ocular uveitis, ocular manifestationsAbstract
Psoriasis is an inflammatory disease characterized by skin involvement given by the presence of well-defined erythemato-squamous plaques that varies according to the clinical form. It is a chronic disease that occurs with outbreaks and remissions. It is considered a multisystemic disease since it can manifest itself in the skin, mucous membranes, nails and joints, as well as the eyes and ocular adnexa in 10% of patients. The eye can be affected with multiple manifestations from mild and superficial involvement to cases of intraocular involvement such as uveitis. The treatment of this pathology includes from topical corticosteroids to biological agents. The objective of this review was to compile the most up-to-date information on psoriasis and its ocular manifestation: uveitis.
References
I. Christophers E. Psoriasis-epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26:314-320.
II. Friedewald VE, Cather JC, Gelfand JM, Gordon KB, et ál. AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol. 2008;15:1631-1643.
III. Egeberg A, Khalid U, Gislason GH, Mallbris L, et ál. Association of Psoriatic Disease With Uveitis: A Danish Nationwide Cohort Study. JAMA Dermatol. 2015;151:1200-1205.
IV. Fraga NA, Oliveira F, Follador I, Rocha B de O, et ál. Psoriasis and uveitis: a literature review. An Bras Dermatol. 2012;87:877-883.
V. Kaldeck R. Ocular psoriasis; clinical review of eleven cases and some comments on treatment. AMA Arch Derm Syphilol. 1953;68:44-49.
VI. Kowsigan M, Amravi S, Jyotirmay B. Biologics in uveitis: An update IJIR. 2019;1-8.
VII. Hassan M, Karkhur S, Bae JH, Halim MS, et ál. New therapies in development for the management of non-infectious uveitis: A review. Clin Exp Ophthalmol. 2019;47:396-417.
VIII. Lambert JR, Wright V. Eye inflammation in psoriatic arthritis. Ann Rheum Dis. 1976;35:354-356.
IX. Erbagci I, Erbagci Z, Gungor K, Bekir N. Ocular anterior segment pathologies and tear film changes in patients with psoriasis vulgaris. Acta Med Okayama. 2003;57:299-303.
X. Rehal B, Modjtahedi BS, Morse LS, Schwab IR, et ál. Ocular psoriasis. J Am Acad Dermatol. 2011;65:1202-1212.
XI. García-Munitis P, Ves-Losada J, Mata E. Uveitis: When the referral is to the pediatrician. Arch Argent Pediatr. 2016;114:272-276.
XII. Durrani K, Foster CS. Psoriatic uveitis: a distinct clinical entity? Am J Ophthalmol. 2005;139:106-111.
XIII. Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT. Characterization of uveitis in patients with psoriatic arthritis. Ann Rheum Dis. 2000;59:67-70.
XIV. Chi CC, Tung TH, Wang J, Lin YS, et ál. Risk of uveitis among people with psoriasis: a nationwide cohort study. JAMA Ophthalmol. 2017;135:415-422.
XV. Amatore F, Villani AP, Tauber M, Viguier M, et ál. Psoriasis Research Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la Société Française de Dermatologie). French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults. J Eur Acad Dermatol Venereol. 2019;33:464-483.
XVI. Jabs DA, Rosenbaum JT, Foster CS, Holland GN, et ál. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492-513.
XVII. Gallego-Pinazo R, Dolz-Marco R, Martínez-Castillo S, Arévalo JF, et ál. Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis. Inflamm Allergy Drug Targets. 2013;12:38-45.
XVIII. Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr, et ál. Fundamentals of Care for Uveitis International Consensus Group. Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative. Ophthalmology. 2018;125:757-773.
XIX. Rosenbaum JT, Bodaghi B, Couto C, Zierhut M, et ál. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review. Semin Arthritis Rheum. 2019;49:438-445.
XX. Ruggiero A, Fabbrocini G, Cacciapuoti S, Cinelli E, et ál. Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: a useful tool to reveal misdiagnosed ocular involvement in psoriasis. J Clin Med. 2021;10:1031
XXI. Capelusnik D, Cavalieri M, Rolón-Campuzano R, Schneeberger E, et ál. Prevalencia y características de uveítis como manifestación extraarticular en espondiloartritis axial. Rev Argent Reumatol. 2018;29:26-31.
XII. Gallego-Pinazo R, Dolz-Marco R, Martínez-Castillo S, Fernando Arévalo J, et ál. Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis. Inflamm Allergy-Drug Targets. 2013;12:38-45.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 on behalf of the authors. Reproduction rights: Argentine Society of Dermatology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.
Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor
